MB
MBX Biosciences, Inc. Common Stock (MBX)
NASDAQ·Healthcare·Biotechnology
$52.35
+1.94%
Mkt Cap $2.62B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (15 analysts)
$94.40
Range $56.00 – $150.00
Implied Upside
+80.3%
Consensus $94.40 vs current $52.35